Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis
Cancer patients contracting SARS-CoV-2 encounter additional challenges due to inflammatory bursts and lymphopenia, which may aggravate breast cancer prognosis. In this in-silico analysis, we identified the potential of miRNAs as new therapeutic targets to treat breast cancer patients infected with C...
Saved in:
| Main Author: | Mukhopadhyay, Debasmita (author) |
|---|---|
| Other Authors: | AlSawaftah, Nour Majdi (author), Husseini, Ghaleb (author) |
| Format: | article |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/11073/21486 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leptomeningeal Metastatic L858R <i>EGFR</i>-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib
by: Aladdin Kanbour (14442123)
Published: (2022) -
Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis
by: Mukhopadhyay, Debasmita
Published: (2021) -
The role of microRNAs in skin cancers
by: Nature Research (16552612)
Published: (2015) -
Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects
by: Rizwan Qureshi (15279193)
Published: (2023) -
MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes
by: Hassan Dehaini (14689341)
Published: (2019)